Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001460507 | SCV001664381 | likely benign | Dilated cardiomyopathy 1G; Autosomal recessive limb-girdle muscular dystrophy type 2J | 2024-02-26 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV003298799 | SCV004005950 | uncertain significance | Cardiovascular phenotype | 2023-04-22 | criteria provided, single submitter | clinical testing | The c.17089C>A variant (also known as p.R5697R), located in coding exon 67 of the TTN gene, results from a C to A substitution at nucleotide position 17089. This nucleotide substitution does not change the arginine at codon 5697. This nucleotide position is highly conserved in available vertebrate species. In silico splice site analysis predicts that this alteration may result in the creation or strengthening of a novel splice acceptor site. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Gene |
RCV004774449 | SCV005387162 | uncertain significance | not provided | 2024-02-27 | criteria provided, single submitter | clinical testing | Not observed at significant frequency in large population cohorts (gnomAD); Has not been previously published as pathogenic or benign to our knowledge; In silico analysis suggests this variant may impact gene splicing. In the absence of RNA/functional studies, the actual effect of this sequence change is unknown. |